Disorderly CD44 gene expression in human cancer cells can be modulated by growth conditions

Journal of Pathology

Volumn 186, Issue 1, 1998, Pages 17-23

  Sugino, Takashi ^a   Yoshida, Kazuhiro ^a   Zhao, Shenru ^a   Goodison, Steven ^b   Tarin, David ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; CD44; Cell culture; Gene expression

Indexed keywords

HERMES ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER STAGING; CELL ADHESION; CELL INTERACTION; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTIGENS, CD44; ANTIGENS, NEOPLASM; BLOTTING, SOUTHERN; CELL DIVISION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0031652734     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199809)186:1<17::AID-PATH138>3.0.CO;2-A     Document Type: Article

References (21)

1. Screaton GR, Bell MV, Jackson DG, et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89: 12 160-12 164.
2. Stamenkovic I, Aruffo A, Amiot M, et al. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 1991; 10: 343-348.
3. Fox SB, Fawcett J, Jackson D, et al. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 1994; 54: 4539-4546.
4. Mackay CR, Terpe HJ, Stauder R, et al. Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 1994; 124: 71-82.
5. Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992; 340: 1053-1058.
6. Wielenga VJM, Heider K-H, Offerhaus GJA, et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993; 53: 4754-4756.
7. Kaufmann M, Heider KH, Sinn HP, et al. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995; 345: 615-619.
8. Birch M, Mitchell S, Hart IR. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res 1991; 51: 6660-6667.
9. Price JE, Polyzos A, Zhang RD, et al. Tumorigenicity and metastasis of human breast carcinoma in nude mice. Cancer Res 1990; 50: 717-721.
10. Folkman J, Moscona A. Role of cell shape in growth control. Nature 1978; 273: 345-349.
11. Tarin D, Bolodeoku H, Hatfill SJ, et al. The clinical significance of malfunction of the CD44 locus in malignancy. J Neuro Oncol 1995; 26: 209-219.
12. Mulder J-WT, Kruyt PM, Sewnath M, et al. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994; 344: 1470-1472.
13. Dall P, Heider K-H, Sinn HP, et al. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Int J Cancer 1995: 60: 471-477.
14. Seelantag WK, Gunthert U, Saremaslani P. et al. CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation. Int J Cancer 1996; 69: 218-224.
15. Fujita N, Yaegashi N, Ide Y, et al. Expression of CD44 in normal versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymphovascular space involvement of cancer cells. Cancer Res 1994; 54: 3992-3998.
16. Sugino T, Gorham H, Yoshida K, et al. Progressive loss of CD44 expression in invasive bladder cancer. Am J Pathol 1996; 149: 873-882.
17. Gunthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24.
18. Driessens MH, Stroeken PJ, Rodriguez NF, et al. Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity. J Cell Biol 1995; 131: 1849-1855.
19. Sugiyama M, Woodman A, Sugino T, et al. Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine. J Clin Pathol: Mol Pathol 1995; 48: 142-147.
20. Matsumura Y, Sugiyama M, Matsumura S, et al. Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. J Pathol 1995; 177: 11-20.
21. Yoshida K, Bolodeoku J, Sugino T, et al. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumours. Cancer Res 1995; 55: 4273-4277.